Understanding immune function and dysfunction.
Evolutionary changes in genes linked to rheumatoid arthritis (RA) may be responsible for higher incidence and earlier onset in Indigenous North American populations. An international team of scientists, co-led by Monash Biomedicine Discovery Institute(BDI) and University of Queensland researchers, embarked on research to look at why RA is more prevalent and severe in Indigenous populations. Monash […]
Monash University scientist, Professor Jamie Rossjohn, has been elected to the Fellowship of the Academy of Medical Sciences in the UK. The Academy of Medical Sciences Fellows are considered the UK’s leading medical scientists, elected for their contribution to biomedical and health research, the generation of new knowledge in medical sciences and its translation into […]
Monash University has signed a major multiyear research and commercialisation deal with Janssen Biotech, Inc. (“Janssen”), one of the Janssen Pharmaceutical companies of Johnson & Johnson, for the early detection and prevention of rheumatoid arthritis, a debilitating autoimmune disease which affects more than 400,000 Australians1 and more than 24.5 million people worldwide2. The agreement was […]
Janssen Biotech funds Monash rheumatoid arthritis research Janssen Biotech, part of global giant Johnson & Johnson, has agreed to fund research by a team of scientists led by one of Monash University’s star researchers into rheumatoid arthritis. The landmark deal means Janssen will have first dibs on new medicines emerging from a research team led […]
Monash University researchers have discovered the mechanism that explains how key genetic risk factors cause or protect people from autoimmune disease such as type 1 diabetes, multiple sclerosis, and Crohn’s disease. Monash University researchers have discovered the mechanism that explains how key genetic risk factors cause or protect people from autoimmune disease such as type […]
